Vestnik Dermatologii i Venerologii (Aug 2017)

Lepra recurrent developed after termination of antileprotic therapy

  • A. A. Kubanov,
  • A. E. Karamova,
  • V. G. Semenova,
  • V. A. Smoliannikova,
  • M. A. Nefedova

DOI
https://doi.org/10.25208/0042-4609-2016-0-6-3-18
Journal volume & issue
Vol. 0, no. 6
pp. 66 – 72

Abstract

Read online

Lepra is an infectious disease, granulomatosis caused by Mycobacterium leprae. It is characterized with prolonged latent period (from 3-5 years to several decades), low transmission, generally lesions of skin and peripheral nervous system. The recurrent of disease is possible after the termination of antileprotic therapy. A case report presented demonstrating the lepra recurrent in female patient 4 years after termination of therapy; that was conducted during 17 years and led to the regression of clinical symptoms and to negative results of bacterioscopic examination of nasal brushings and scratch samples from sites of former eruptions. This case should call attention of dermatologists and other physicians to the problem of leprosy recurrent diagnosis in previously observed and deregistered patients.

Keywords